Treatment with Shuyu capsule increases 5-HT1AR level and activation of cAMP-PKA-CREB pathway in hippocampal neurons treated with serum from a rat model of depression

Mol Med Rep. 2018 Mar;17(3):3575-3582. doi: 10.3892/mmr.2017.8339. Epub 2017 Dec 22.

Abstract

Depressive disorder (DD) is one of the typical affective disorders with a high morbidity, high suicide rate and high recurrence rate. Dysfunction of the 5‑hydroxytryptamine 1A receptor (5‑HT1AR) in the brain may serve an important role in the pathogenesis of DD. Currently, selective serotonin reuptake inhibitors are the first line antidepressants with 60‑70% efficacy and severe adverse effects. Previous studies have demonstrated that Chinese herbal medicines, including the Shuyu capsule (SYC), are effective antidepressants with few side effects. However, the mechanism remains unclear. In the present study, the effects of the SYC on the 5‑HT1AR level and the activation of adenylyl cyclase‑cyclic adenosine monophosphate (cAMP)‑protein kinase A (PKA)‑cAMP response element‑binding (CREB) signaling pathway that 5‑HT1AR mediates in the cells of hippocampal neurons were investigated in vitro. The SYC demonstrated an antidepressant effect similar to that of fluoxetine in a rat depression model. Treatment of hippocampal neurons with the serum of depressive rats resulted in a decrease in the 5‑HT1AR protein level and the activation of the cAMP‑PKA‑CREB signaling pathway in hippocampal neurons. Exposure to the serum of rats that received chronic mild stress plus SYC treatment led to no alterations in the 5‑HT1AR level or the activation of the cAMP‑PKA‑CREB signaling pathway compared with those of cells exposed to normal rat serum. This effect is similar to the effects of 5‑HT1AR antagonist WAY‑100635. In addition, the 5‑HT1A agonist 8‑hydroxy‑(dipropylamino) tetralin did not antagonize the effects of the SYC. Furthermore, the SYC exhibited an increased effect compared with fluoxetine on 5‑HT1AR levels and CREB activation. The present study suggested that the SYC functions by increasing 5‑HT1AR protein levels and the activation of the 5‑HT1AR‑mediated cAMP‑PKA‑CREB signaling pathway in hippocampal neurons.

Keywords: depressive disorder; Chinese herbal medicine; Shuyu capsule; 5-hydroxytryptamine 1A receptor; signaling pathway; hippocampal neuron.

MeSH terms

  • Animals
  • Antidepressive Agents / pharmacology*
  • Antidepressive Agents / therapeutic use
  • Behavior, Animal / drug effects
  • Body Weight / drug effects
  • CREB-Binding Protein / metabolism
  • Cells, Cultured
  • Cyclic AMP / metabolism
  • Cyclic AMP-Dependent Protein Kinases / metabolism
  • Cyclohexanes / pharmacology
  • Depressive Disorder / drug therapy
  • Depressive Disorder / pathology
  • Disease Models, Animal
  • Drugs, Chinese Herbal / pharmacology*
  • Drugs, Chinese Herbal / therapeutic use
  • Hippocampus / cytology
  • Hippocampus / metabolism
  • Male
  • Neurons / cytology
  • Neurons / drug effects
  • Neurons / metabolism*
  • Piperazines / pharmacology
  • Rats
  • Rats, Wistar
  • Receptor, Serotonin, 5-HT1A / metabolism*
  • Signal Transduction / drug effects*
  • Up-Regulation / drug effects*

Substances

  • Antidepressive Agents
  • Cyclohexanes
  • Drugs, Chinese Herbal
  • Piperazines
  • WAY 101363
  • Receptor, Serotonin, 5-HT1A
  • Cyclic AMP
  • CREB-Binding Protein
  • Cyclic AMP-Dependent Protein Kinases